Evidence map›Paper›PMID 22657748›Full record

Trial reportJournal of substance abuse treatment2013

Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.

Dennis M Donovan, Dennis C Daley, Gregory S Brigham, Candace C Hodgkins, Harold I Perl, Sharon B Garrett, Suzanne R Doyle, Anthony S Floyd, Patricia C Knox, Christopher Botero and 7 more

Erratum issued Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT00573183 (Stimulant Abuser Groups to Engage in 12-Step), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00573183 phase3completednot on this map

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

TypeinterventionalSponsorUniversity of WashingtonRan2008 to 2010Enrolled471ConditionsDrug AbuseArmsSTAGE-12, Treatment as Usual
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Psychosocial interventions for stimulant use disorder.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. The relationship of therapeutic alliance and treatment delivery fidelity with treatment retention in a multisite trial of twelve-step facilitation.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2015
    Trial
  6. Applying an ensemble classification tree approach to the prediction of completion of a 12-step facilitation intervention with stimulant abusers.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2014
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Review
  19. Overeaters Anonymous: An Overlooked Intervention for Binge Eating Disorder.International journal of environmental research and public health · 2021
    Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Kau'ibaumhofer, Nicole [corrected to Kau'i Baumhofer, Nicole]
5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Dennis M DonovanAlcohol a Drug Abuse Institute University of Washington, Seattle, WA, USA. ddonovan@u.washington.edu
Dennis C Daley
Gregory S Brigham
Candace C Hodgkins
Harold I Perl
Sharon B Garrett
Suzanne R Doyle
Anthony S Floyd
Patricia C Knox
Christopher Botero
Thomas M Kelly
Therese K Killeen
Carole Hayes
Nicole Kau'i Baumhofer
Nicole Kau'ibaumhofer
Cindy Seamans
Lucy Zammarelli
University of Washington · USUniversity of Pittsburgh · USGateway Community Services (United States) · USKaneka (United States) · USMedical University of South Carolina · USNational Institute on Drug Abuse · USWillamette University · US

Funding

Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
Concept ProjectU10DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2005 to 2015
$22.6M
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORKU10DA013036 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 1999 to 2010
$18.5M
CLINICAL TRIAL RESEARCH PROJECT COREU10DA020036 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DALEY, DENNIS C · 2005 to 2015
$14.1M
NIDA NIH HHS U10 DA013036NIDA NIH HHS U10 DA013045NIDA NIH HHS U10 DA013714NIDA NIH HHS U10 DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10 DA020024NIDA NIH HHS U10 DA020036NIDA NIH HHS U10DA13036NIDA NIH HHS U10DA13045NIDA NIH HHS U10DA13714NIDA NIH HHS U10DA13720NIDA NIH HHS U10DA13727NIDA NIH HHS U10DA13732NIDA NIH HHS U10DA20024NIDA NIH HHS U10DA20036NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

aimsThe study evaluated the effectiveness of an 8-week combined group plus individual 12-step facilitative intervention on stimulant drug use and 12-step meeting attendance and service.

designMultisite randomized controlled trial, with assessments at baseline, mid-treatment, end of treatment, and 3- and 6-month post-randomization follow-ups (FUs).

settingIntensive outpatient substance treatment programs.

participantsIndividuals with stimulant use disorders (n = 471) randomly assigned to treatment as usual (TAU) or TAU into which the Stimulant Abuser Groups to Engage in 12-Step (STAGE-12) intervention was integrated. MEASUREMENTS: Urinalysis and self-reports of substance use and 12-step attendance and activities.

interventionGroup sessions focused on increasing acceptance of 12-step principles; individual sessions incorporated an intensive referral procedure connecting participants to 12-step volunteers.

findingsCompared with TAU, STAGE-12 participants had significantly greater odds of self-reported stimulant abstinence during the active 8-week treatment phase; however, among those who had not achieved abstinence during this period, STAGE-12 participants had more days of use. STAGE-12 participants had lower Addiction Severity Index Drug Composite scores at and a significant reduction from baseline to the 3-month FU, attended 12-step meetings on a greater number of days during the early phase of active treatment, engaged in more other types of 12-step activities throughout the active treatment phase and the entire FU period, and had more days of self-reported service at meetings from mid-treatment through the 6-month FU.

conclusionsThe present findings are mixed with respect to the impact of integrating the STAGE-12 intervention into intensive outpatient drug treatment compared with TAU on stimulant drug use. However, the results more clearly indicate that individuals in STAGE-12 had higher rates of 12-step meeting attendance and were engaged in more related activities throughout both the active treatment phase and the entire 6-month FU period than did those in TAU.

Indexed as

Patient ComplianceSelf-Help GroupsAdultCentral Nervous System StimulantsFemaleFollow-Up StudiesHumansMaleMiddle AgedNational Institute on Drug Abuse (U.S.)RecurrenceReferral and ConsultationSeverity of Illness IndexSubstance Abuse DetectionSubstance-Related DisordersTime FactorsCentral Nervous System Stimulants

Identifiers

PMID22657748
PMCPMC3434261
OpenAlexW2135578025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.